|
|
Volumn 22, Issue 5, 2007, Pages 350-357
|
|
Transporter-mediated hepatic uptake of ulifloxacin, an active metabolite of a prodrug-type new quinolone antibiotic prulifloxacin, in rats.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,3 DIOXOLANE DERIVATIVE;
6 FLUORO 1 METHYL 4 OXO 7 (1 PIPERAZINYL) 4H 1,3 THIAZETO[3,2 A]QUINOLINE 3 CARBOXYLIC ACID;
AGENTS AFFECTING WATER, MOLECULE OR ION TRANSPORT;
ANTIINFECTIVE AGENT;
CARRIER PROTEIN;
PIPERAZINE DERIVATIVE;
PRODRUG;
PRULIFLOXACIN;
QUINOLONE DERIVATIVE;
ANIMAL;
AREA UNDER THE CURVE;
ARTICLE;
BIOLOGICAL MODEL;
BIOTRANSFORMATION;
CYTOLOGY;
DRUG ANTAGONISM;
DRUG EFFECT;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER;
LIVER CELL;
MALE;
METABOLIC CLEARANCE RATE;
METABOLISM;
RAT;
SPRAGUE DAWLEY RAT;
TRANSPORT AT THE CELLULAR LEVEL;
ANIMALS;
ANTI-BACTERIAL AGENTS;
AREA UNDER CURVE;
BIOLOGICAL TRANSPORT;
BIOTRANSFORMATION;
CARRIER PROTEINS;
DIOXOLANES;
FLUOROQUINOLONES;
HEPATOCYTES;
INJECTIONS, INTRAVENOUS;
LIVER;
MALE;
MEMBRANE TRANSPORT MODULATORS;
METABOLIC CLEARANCE RATE;
MODELS, BIOLOGICAL;
PIPERAZINES;
PRODRUGS;
QUINOLONES;
RATS;
RATS, SPRAGUE-DAWLEY;
|
|
EID: 38449092450
PISSN: 13474367
EISSN: None
Source Type: Journal
DOI: 10.2133/dmpk.22.350 Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
